LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC) (IMUC), a biotechnology company, announced today that it has appointed Peter Brooks, Ph.D. and Sherie Morrison, Ph.D. to the company’s Scientific Advisory Board. Dr. Brooks of the Maine Medical Center Research Institute brings extensive expertise in the monoclonal antibody area, having participated in the research and development of multiple anti-cancer compounds. Dr. Morrison of the University of California, Los Angeles is a world renowned antibody researcher, having published hundreds of papers and patents and who has also acted as keynote speaker at a number of antibody conferences.
